PHERAZINE W/ CODEINE Drug Patent Profile
✉ Email this page to a colleague
When do Pherazine W/ Codeine patents expire, and when can generic versions of Pherazine W/ Codeine launch?
Pherazine W/ Codeine is a drug marketed by Halsey and is included in one NDA.
The generic ingredient in PHERAZINE W/ CODEINE is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.
Summary for PHERAZINE W/ CODEINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 10 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHERAZINE W/ CODEINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PHERAZINE W/ CODEINE
US Patents and Regulatory Information for PHERAZINE W/ CODEINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Halsey | PHERAZINE W/ CODEINE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 088739-001 | Dec 23, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |